Search Results
Mar 23, 2026, 08:30 ET Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
release; (ii) Talphera's developmental product candidates may not be beneficial to patients or healthcare providers or be successfully commercialized; (iii) risks relating to Talphera's ability to obtain regulatory approvals for its developmental product candidates; (iv) risks related to the ability of Talphera
More news about: Talphera, Inc.
Mar 23, 2026, 07:00 ET Quarterhill Reports Fourth Quarter and Full Year 2025 Financial Results
MeasuresWe use the non-IFRS financial measure "Adjusted EBITDA" to mean net loss adjusted for (i) income taxes, (ii) nance expense or income; (iii) amortization and impairment of intangibles; (iv) other charges and other one-time items; (v) depreciation of right-of-use assets and property, plant
More news about: Quarterhill Inc.
Mar 23, 2026, 06:45 ET Sealed Air Announces Completion of Regulatory Approvals for Acquisition by CD&R
Transaction; (ii) the risk that the parties to the merger agreement may not be able to satisfy the conditions to the Transaction in a timely manner or at all; (iii) the risk of any litigation relating to the Transaction; (iv) the risk that the Transaction and its announcement could have an adverse effect on the
More news about: Sealed Air
Mar 23, 2026, 06:04 ET WuXi AppTec Beat Full-Year Guidance and Achieved Record Performance in 2025
As of year-end, our pipeline reached 3,452 molecules, including 83 commercial projects, 91 in phase III, 377 in phase II and 2,901 in phase I and pre-clinical stages. Notably, commercial and phase III projects increased by 22 in 2025.ii. We continued to build small molecule capacity. In 2025,
More news about: WuXi AppTec
Mar 22, 2026, 18:51 ET Wolf Haldenstein Adler Freeman & Herz LLP announces that it has filed a class action lawsuit against ChowChow Cloud International Holdings Limited (NYSE American: CHOW)
and risk disclosures omitted any mention of the realized risk of fraudulent trading or market manipulation used to drive the Company's stock price; (iii) that, as a result, CHOW securities were at unique risk of a sustained suspension in trading by NYSE American and severe volatility-induced decline;
More news about: Wolf Haldenstein Adler Freeman & Herz LLP
Mar 22, 2026, 09:12 ET PLUG DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Plug Power (PLUG) Investors of Securities Class Action Deadline on April 3, 2026
facilities necessary to receive those funds; (ii) as such, Plug Power was likely to pivot toward more modest projects with less commercial upside; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.On October 7, 2025, Plug Power issued
More news about: Faruqi & Faruqi, LLP
Mar 22, 2026, 08:45 ET LAKE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Lakeland Industries (LAKE) Investors of Securities Class Action Deadline on April 24, 2026
these businesses on Lakeland's financial results, as well as the overall strength and quality of Pacific Helmets' and Jolly's respective operations; (iii) Lakeland's business and financial results were significantly deteriorating because of, inter alia, tariff-related headwinds and timing, certification
More news about: Faruqi & Faruqi, LLP
Mar 22, 2026, 08:33 ET RARE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026
Ultragenyx' Phase III Orbit study would fail to achieve a statistically significant reduction in annualized fracture rate ("AFR"), such that the second interim analysis could be performed and presented to the investing public; and (ii) in truth, Ultragenyx' optimism in the Phase III Orbit study's results
More news about: Faruqi & Faruqi, LLP
Mar 21, 2026, 21:30 ET World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target
development and manufacturing solutions. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing.WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously
More news about: WuXi Biologics
Mar 20, 2026, 22:39 ET Gemini Space Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Gemini Space Station, Inc. - GEMI
platform; (ii) the Company had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, the Company's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that the
More news about: ClaimsFiler
Mar 20, 2026, 22:36 ET Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
result, the administration of DCCR to treat hyperphagia in individuals with PWS posed materially greater safety risks than disclosed by the Company; and (iii) consequently, DCCR had materially lower commercial viability and undisclosed risks related to the likelihood of significant and widespread adverse events
More news about: ClaimsFiler
Mar 20, 2026, 22:35 ET Apollo Global Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Apollo Global Management, Inc. - APO
regarding the Company's business; (ii) as a result, the Company's assertion that Apollo Global had never done business with Jeffrey Epstein was untrue; (iii) because of the entanglement between Apollo Global's leaders and Jeffrey Epstein, the harm to the Company's reputation was more than a mere possibility;
More news about: ClaimsFiler
Mar 20, 2026, 22:32 ET Enphase Energy Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Enphase Energy, Inc. - ENPH
ability to offset the impacts resulting from the termination of the Residential Clean Energy Credit pursuant to Internal Revenue Code Section 25D; and (iii) as a result, the Company overstated its financial and operational prospects.The case is Tripathi v. Enphase Energy, Inc., No. 26-cv-01380.About
More news about: ClaimsFiler
Mar 20, 2026, 22:29 ET Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
Company announced the "results from the Phase 3 Orbit and Cosmic studies for setrusumab (UX143) in Osteogenesis Imperfecta" disclosing that both its Phase III Orbit and Cosmic studies failed to demonstrate that setrusumab triggered a statistically significant reduction in annualized fracture rates for patients
More news about: ClaimsFiler
Mar 20, 2026, 21:05 ET EOSE INVESTOR ALERT: Eos Energy Enterprises, Inc. Investors with Substantial Losses Have Opportunity to Lead the Eos Energy Class Action Lawsuit
set guidance; (ii) Eos Energy's battery line downtime was running well above industry norms, the design intent of the line, and internal forecasts; (iii) Eos Energy was experiencing delays in the ability for its automated bipolar production to hit quality targets; and (iv) Eos Energy's inadequate systems
More news about: Robbins Geller Rudman & Dowd LLP
Mar 20, 2026, 20:15 ET Camping World Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - RGRD Law
optimize profit using "data analytics"; (ii) Camping World overstated the retail demand of consumers it was experiencing and/or reasonably expected; (iii) as a result, Camping World would require "strict, corrective inventory management objectives," negatively impacting gross profit and margins; and (iv)
More news about: Robbins Geller Rudman & Dowd LLP
Mar 20, 2026, 18:08 ET GEMI Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Gemini Space Station, Inc.
platform; (ii) Gemini had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, Gemini's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that Gemini
More news about: Robbins LLP
Mar 20, 2026, 16:30 ET QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data
a primary control for AMT-130.Hidden Requirements: That uniQure downplayed the necessity of a sham-controlled surgery arm for Phase III—a requirement the FDA now claims was never waived.Timeline Deception: That defendants misled investors regarding the timing of a Biologics
More news about: Hagens Berman Sobol Shapiro LLP
Mar 20, 2026, 16:05 ET FiEE, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results
(i) the future financial position and performance of the Company, (ii) our ability to successfully implement our strategic business transformation, (iii) our long-term growth objectives and opportunities, (iv) our commitment to investing in R&D to expand our service offerings, enhance customer experience,
More news about: FiEE, Inc.
Mar 20, 2026, 14:30 ET HONEYWELL ANNOUNCES PRICING OF ITS DEBT TENDER OFFERS
to meet the conditions related thereto; (ii) the possibility that the Spin-Off will not be completed within the anticipated time period or at all; (iii) the possibility that the Spin-Off will not achieve its intended benefits; (iv) the impact of the Spin-Off on Honeywell's and Aerospace's businesses
More news about: Honeywell
Mar 20, 2026, 13:47 ET PLANET HOLLYWOOD HOTEL & CASINO LANDS IN TBILISI WITH GEORGIA'S FIRST INTEGRATED RESORT DESTINATION
alliances, licensing, structuring, business planning, financing, predevelopment, construction, and beyond.About A. William (Bill) Allen IIIBill Allen is a legendary leader in the restaurant and hospitality industry, distinguished by his strategic foresight and pioneering spirit.
More news about: Planet Hollywood
Mar 20, 2026, 12:05 ET Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026
clinical outcomes and higher satisfaction.1,2 Ninety-four percent of patients who completed 18 months of lecanemab treatment in the Phase III Clarity AD study chose to continue maintenance treatment by enrolling in the subsequent open-label, long-term extension (OLE) study. In the OLE of the
More news about: Eisai Inc.
Mar 20, 2026, 10:00 ET Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting
including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin, NKTR-0165, NKTR-0166 and NKTR-422are in clinical development and the risk of failure is high and can unexpectedly occur at any stage
More news about: Nektar Therapeutics
Mar 20, 2026, 09:00 ET Bernstein Litowitz Berger & Grossmann LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Driven Brands Holdings Inc. Common Stock
SUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION AND PROPOSED SETTLEMENT; (II) SETTLEMENT HEARING; AND (III) MOTION FOR ATTORNEYS' FEES AND LITIGATION EXPENSESTO: All persons and entities who purchased the common stock of Driven
More news about: Bernstein Litowitz Berger & Grossmann LLP
Mar 20, 2026, 08:00 ET HONEYWELL ANNOUNCES EARLY PARTICIPATION RESULTS AND UPSIZING OF ITS DEBT TENDER OFFERS
to meet the conditions related thereto; (ii) the possibility that the Spin-Off will not be completed within the anticipated time period or at all; (iii) the possibility that the Spin-Off will not achieve its intended benefits; (iv) the impact of the Spin-Off on Honeywell's and Aerospace's businesses
More news about: Honeywell